The postdrome of the acute migraine attack

被引:68
|
作者
Kelman, L [1 ]
机构
[1] Headache Ctr Atlanta, Atlanta, GA 30342 USA
关键词
headache; migraine; postdrome; resolving headache;
D O I
10.1111/j.1468-2982.2005.01026.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This study was performed to document the frequency, duration and types of symptoms of postdrome in migraine patients. Eight hundred and twenty-seven consecutive headache clinic patients (IHS 1.1, 1.2 and 1.5.1) were evaluated at first visit. Postdrome frequency, duration and characteristics were analysed. Sixty-eight per cent of 827 patients reported postdrome (69.1% females; 56.8% males, P < 0.007). The average duration of the postdrome was 25.2 h. Fifty-six per cent had postdrome for <= 12 h, 32% for 12-24 h, 88% for <= 24 h, and 12% for > 24 h. The commonest symptoms were tiredness (71.8%), head pain (33.1%), cognitive difficulties (11.7%), 'hangover' (10.7%), gastrointestinal symptoms (8.4%), mood change (6.8%), and weakness (6.2%). Patients with postdrome compared with patients without postdrome have more characteristic and more frequent migraine features. This study demonstrated postdrome in 68% of patients, duration <= 24 h in most patients, more often associated with a full-blown migraine attack, more common in females, and with commonest symptoms being tiredness and low-grade headache.
引用
收藏
页码:214 / 220
页数:7
相关论文
共 50 条
  • [41] POSTDROME
    Shewmaker, Michael
    SEWANEE REVIEW, 2021, 129 (03) : 468 - 469
  • [42] Alterations in attention, fatigue and alertness associated with the premonitory and postdrome stages of triggered migraine attacks
    Karsan, Nazia
    Bose, Pyari
    Thompson, Charlotte
    Goadsby, Peter J.
    CEPHALALGIA, 2017, 37 : 160 - 161
  • [43] Economic evaluation of acute migraine attack treatment with triptans in Spain
    Gracia-Naya, M
    Gutiérrez, JR
    Jiménez, AL
    García, PG
    NEUROLOGIA, 2005, 20 (03): : 121 - 132
  • [44] Newer Horizon for Treatment of Acute Attack of Migraine: Lasmiditan and Ubrogepant
    Maitra, Arpita
    Mukhopadhyay, Sabyasachi
    Das, Abhijit
    Choudhury, Shouvik
    NEUROLOGY INDIA, 2021, 69 (06) : 1759 - 1762
  • [45] EFFERVESCENT ERGOTAMINE TARTRATE (EFFERGOT) IN THE TREATMENT OF THE ACUTE MIGRAINE ATTACK
    BLOWERS, AJ
    CAMERON, EGM
    LAWRENCE, ER
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1981, 35 (05): : 188 - 190
  • [46] Efficacy of intravenous propacetamol hydrochloride in the treatment of an acute attack of migraine
    Zhang, Aiwu
    Jiang, Tao
    Luo, Yifeng
    Zheng, Zhenyang
    Shi, Xiaolei
    Xiao, Zijian
    Fang, Yannan
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (07) : 629 - 632
  • [47] Sensitization of central trigeminal nociception during acute migraine attack
    Kaube, H
    Katsarava, Z
    Przywara, S
    Drepper, J
    Ellrich, J
    Diener, HC
    NEUROLOGY, 2001, 56 (08) : A220 - A220
  • [48] Investigating thiol/disulfide homeostasis in acute migraine attack with aura
    Horasanli, Bahriye
    Aydin, Merve
    Sumlu, Esra
    Sak, Zeynep Caliskan
    Ozsahin, Aysun
    Oguz, Esra Firat
    Erel, Ozcan
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2022, 13 (02): : 236 - 240
  • [50] Subarachnoid hemorrhage mimicking an acute migraine attack: A case report
    Bhattarai, Himal Bikram
    Bhusal, Amrit
    Bhattarai, Ganesh
    Basnet, Bibhusan
    Gautam, Swotantra
    Koirala, Sabina
    Uprety, Manish
    Adhikari, Bibhuti
    Pokhrel, Ritu
    Katwal, Shailendra
    SAGE OPEN MEDICAL CASE REPORTS, 2024, 12